Medical/Pharmaceuticals
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
* Recommendation follows an Article 20 non-pharmacovigilance procedure * Patients currently on TAVNEOS treatment should consult their treating physician ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the...
2026-06-26 21:06
4958
Beyond Injections: S-CELL Unveils Breakthrough "Endogenous GLP-1" Formula Powered by Akkermansia P9 Signaling and CoreBiome® Technology
HONG KONG, June 26, 2026 /PRNewswire/ -- S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebiotic and Probiotic) supplement. This pioneering formula represents a paradigm shift in weight manageme...
2026-06-26 14:42
6450
Everest Medicines Announces China NMPA Acceptance of the Biologics License Application for LEROCHOL® in Adults with Hypercholesterolemia
SHANGHAI, June 26, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that China's National Medical Products...
2026-06-26 10:08
8426
Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias
EPLive 2026 included 1,600 of the world's top cardiac electrophysiology experts AUSTIN, Texas, June 26, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its eighth international symposium on complex arrhythmias on May 28-29, 2026. This year's...
2026-06-26 02:55
7067
Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer
Racura Oncology has dosed the first patient in the HARNESS-1 Phase 1a/b trial of RC220 in combination with osimertinib for EGFR-mutant non-small cell lung cancer. The study will assess safety, pharmacokinetics, ctDNA dynamics and early clinical activity of RC220 as a strategy to address therapeut...
2026-06-25 22:51
6017
FIT KING Highlights How Different Consumer Routines Are Shaping At-Home Recovery Needs
The wellness brand outlines how its at-home recovery lineup matches active lifestyles, busy workdays, travel routines, first-time users, and everyday home wellness needs NEW YORK, June 25, 2026 /PRNewswire/ -- As recovery continues to move beyond elite athletics and into everyday wellness, FIT K...
2026-06-25 21:00
6583
CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex for Sugemalimab across Australia and New Zealand
* Arrotex, the pharmaceutical commercialization platform of DBG, Australia's leading diversified healthcare group, will be responsible for the registration, market access, and commercialization of sugemalimab in Australia and New Zealand. * This partnership marks sugemalimab's fifth internati...
2026-06-25 17:44
7752
Haier Biomedical Debuts Innovative Automated Low-Carbon Cold Storage Products at Two Major Global Industry Trade Fairs
From Europe Biobank Week 2026 in Prague to Interphex Week Tokyo 2026, Haier
Biomedical continuously strengthens global life sciences market presence
through localized innovative products and profound ecosystem partnerships
QINGDAO, China, June 25, 2026 /PRNewswire/ -- Haier Biomedical
2026-06-25 17:34
8926
Malaysian Patient Underwent Advanced Heart Procedure at SinoUnited Health
SHANGHAI, June 25, 2026 /PRNewswire/ -- A Malaysian patient has successfully undergone pulse field ablation (PFA) for persistent atrial fibrillation (AF) in Shanghai. The procedure, performed by internationally renowned cardiac electrophysiologist Dr. Feifan Ouyang, has successfully restored the ...
2026-06-25 14:15
7787
C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China's MAH Framework
CHENGDU, China, June 25, 2026 /PRNewswire/ -- On June 23, 2026, C-Ray Therapeutics (Chengdu) Co., Ltd. ("C-Ray Therapeutics") completed on-site inspections conducted by a panel of experts from the Sichuan Provincial Center for Drug Evaluation and the National Defense Science and Industry Adminis...
2026-06-25 11:33
7223
Dimora Medical has joined the NPIAP Corporate Advisory Council as an Honorary Member
NEW YORK, June 24, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, has officially joined the National Pressure Injury Advisory Panel (NPIAP) as a corporate member, marking a new step in its engagement with the global clinical community focused on pre...
2026-06-25 11:24
8719
ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific
Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies SHANGHAI, June 25, 2026 /PRNewswire/ -- ATLATL Innovation Center ("ATLATL"), a global innovation platform for life science research and development, and Samsung Bioepis C...
2026-06-25 07:30
9078
Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
ABU DHABI, UAE, June 25, 2026 /PRNewswire/ -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health – Abu Dhabi (DoH) has announced a collaboration with global pharmaceutical leader MSD (Merck & Co., Inc., Rahway, New...
2026-06-25 03:15
8646
HKeyBio Debuts HKEY-ExE™ 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development
The EoE-centered framework supports disease modeling, multidimensional efficacy endpoints, type 2 biomarker analysis, and cross-indication translational research BOSTON and SUZHOU, China, June 24, 2026 /PRNewswire/ -- HKeyBio, a preclinical contract research organization focused on autoimmune an...
2026-06-24 21:18
6598
Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease Research
Dataset from more than 7,500 participants expands multiomic analysis in rare disease research by combining metabolomics with genomic and clinical data MORRISVILLE, N.C., June 24, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, dia...
2026-06-24 21:00
5575
HKeyBio Launches NHP Fast-Tox Program for Accelerating Non-GLP NHP Safety Risk Screening
The program supports early tolerability assessment, PK/TK-linked safety evaluation, immune-related risk screening, and pre-GLP dose design for biologics and immunomodulatory drug programs BOSTON and SUZHOU, China, June 24, 2026 /PRNewswire/ -- HKeyBio, a preclinical CRO focused on autoimmune and...
2026-06-24 20:36
6077
IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
* IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. * Waters Biosciences' technologies, including BD FACSDiscover™ and BD Rhapsody™ Instruments, will be used with IMU's AI analy...
2026-06-24 20:00
6933
Tarek Samad appointed EVP, Head of Research & Development at Lundbeck
VALBY, Denmark, June 24, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that Tarek Samad has been appointed Executive Vice President and Head of Research & Development (R&D) and will join the Executive Leadership Team (ELT) effective 1 September 2026. Tarek Samad succeeds Johan ...
2026-06-24 18:19
8181
Yidu Tech's Gong Yingying at Summer Davos: Building Evidence Infrastructure to Expand Access to Innovative Medicines
DALIAN, China, June 24, 2026 /PRNewswire/ -- On June 23, at the 17th Annual Meeting of the New Champions (Summer Davos 2026) hosted by the World Economic Forum in Dalian, Gong Yingying, Founder and Chairlady of Yidu Tech, participated in the panel discussion "Faster Drugs, Better Access?". She sh...
2026-06-24 17:30
8506
World's First Solid Tumor CAR-T Approved: Jiahui International Cancer Center Provides Access for Patients Worldwide
SHANGHAI, June 24, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) welcomes the approval of Satri-cel (CT041, Kaileimei®), the world's first CAR-T cell therapy approved for the treatment of a solid tumor, marking a historic milestone in cancer care and opening new possibilities for...
2026-06-24 17:01
6061
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth
[Picked up by 263 media titles]
2026-10-05 13:24
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
24889